The drugs Victoza and Byetta were created to treat type 2 diabetes, but they are actually causing people to develop other physical problems. They are incretin mimetics drugs whose job it is to control blood sugar for patients diagnosed with type 2 diabetes. These medications are instrumental in helping the pancreas to produce the insulin that needs to be released into the bloodstream. Victoza and Byetta also prevent the pancreas from secreting too much glucagon into the bloodstream, and this keeps glucose at normal levels. The Job of the Pancreas Sugar is metabolized in the bloodstream with the help of the insulin and glucagon that is created in the pancreas. The pancreas also releases enzymes into the small intestine to aid in digestion. If these enzymes become activated within the pancreas before they are released into the small intestine, they launch an attack on the pancreas. Acute Pancreatitis When the pancreas suddenly becomes inflamed, the condition is called "acute pancreatitis," and it is a disorder that may damage the organ. In most cases, gallstones or serious alcohol use cause acute pancreatitis, but medicines, surgeries, accidents, metabolic disorders and infections have also been proven to cause this infirmity. The symptoms are moderate physical distress and pain, and it can be life-threatening in rare instances. Those who receive treatment for this malady very often experience a full recovery. Lawsuit against Novo Nordisk, Inc. and Eli Lilly and Company Linda Jean Howard of Alabama recently filed a lawsuit against Novo Nordisk, Inc. and Eli Lilly and Company the manufacturers of Victoza and Byetta after developing acute pancreatitis. The plaintiff suffers from type 2 diabetes and was prescribed this drug to treat the condition. At the time, the patient was unaware that these two medications were known to cause the type of side effects that she began to experience, and she is not the only one to make these complaints about these medications. The U.S. Food and Drug Administration recorded several complaints against Victoza and Byetta. Between October of 2006 and February of 2009, there were 88 reports of pancreatitis that were related to these two drugs. A total of 66 were so severe that the patients required hospitalization with four requiring a stay in the intensive care unit. On closer examination, researchers found that 21 percent of those who developed pancreatitis as a result of taking Victoza and Byetta acquired the malady within 30 days of beginning to ingest the drug. More than 50 percent of these pancreatitis patients began to recover after they ceased taking Victoza and Byetta. The Link between Victoza and Byetta and Cancer Researchers have also discovered a link between Victoza and Byetta and cancer of the pancreas. A University of California, Los Angeles study that was published in the medical journal Diabetes showed that some patients that take incretin mimicking medications such as Byetta have abnormal cells within the pancreas known as "dysplasia." In her lawsuit, Howard requests that Novo Nordisk, Inc. and Eli Lilly and Company be ordered to pay $75,000 for the damage that was done to her along with reimbursement for her medical bills and miscellaneous expenses. Contact an Attorney Today If you or a loved one is suffering from acute pancreatitis, pancreatic cancer or some other malady and you believe it may be related to the drugs Victoza and Byetta, you are entitled to hire a pharmaceutical lawsuit lawyer. A drug lawsuit attorney is a highly knowledgeable professional who knows exactly which medical experts can determine whether or not your condition was caused by Victoza and Byetta. You may be eligible to join a class action lawsuit, so you will need a class action lawsuit attorney. Contact an attorney today so that you can be compensated for your injuries due to these two diabetes drugs.